ThrombUS+ D8.2: Dissemination and Communication Plan and Activities - Part A

D8.2. Dissemination and Communication Plan and Activities Part A K. Pavlidi [SciGen] Due Date: 31 March 2024 Delivery Date: 31 March 2024 Revision Date: 12 November 2025 Horizon Innovation Action | Agreement No. 101137227 HORIZON-HLTH-2023-TOOL-05-05 Co-funded by the European Union D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 ii ThrombUS+ Consortium ATHENA Research and Innovation Center in Information, Communication and Knowledge Technologies, Greece Eleni Kaldoudi [email protected] KTU Kaunas University of Technology Lithuania Vaidotas Marozas [email protected] VERMON Vermon SA France Mathieu Legros [email protected] FRAUNHOFER Institute for Photonic Microsystems, Fraunhofer Germany Nicolas Lange [email protected] TELEMED Telemed Ultrasound Medical Systems Lithuania Dmitry Novikov [email protected] EchoNous EchoNous Inc USA Pavlos Moustakidis [email protected] MEDIS medis Medizinische Messtechnik GmbH Germany Susann Balling [email protected] ComfTech ComfTech SLR Italy Lara Alessia Moltani [email protected] TAU Faculty of Medicine and Health Technology Tampere University, Finland Antti Vehkaoja [email protected] LMSU Lithuanian University of Health Science Lithuania Andrius Macas [email protected] GNP Papageorgiou General Hospital Greece Maria Bigaki [email protected] CSS-IRCCS Home Relief of Suffering Hospital Italy Elvira Grandone e.grand[email protected] HSV Simon Veil Hospital France Maxime Gautier [email protected] VDE Association for Electrical, Electronic & Information Technologies, Germany Thorsten Prinz thorsten[email protected] MEDEA MEDEA SRL Italy Pietro Dionisio [email protected] PHAZE Clinical Research and Pharma Consulting SA Greece Spiros Anagnostopoulos [email protected] PBY PredictBy Research and Consulting SL Spain Frans Folkvord [email protected] SciGen SciGen Technologies SA Greece Katerina Pavlidi [email protected] Disclaimer This document contains description of the ThrombUS+ project work, findings, and products. The authors of this document have taken any available measure for its content to be accurate, consistent and lawful. However, neither the project consortium as a whole nor the individual partners that implicitly or explicitly participated in the creation and publication of this document hold any sort of responsibility that might occur as a result of using its content. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority HADEA can be held responsible for them. In case you believe that this document harms in any way intellectual property held by you as a person or as a representative of an entity, please do notify us immediately. ThrombUS+ is an Innovation Action Project co-funded by the European Union, under HORIZON-HLTH-2023-TOOL05-05 “Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery”. D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 iii Document Control Page Project Grant Agreement: 101137227 Acronym: ThrombUS+ Title: Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis Type: Innovation Action Start: 1 January 2024 End: 30 June 2027 Programme: Horizon Europe Call Identifier: HORIZON-HLTH-2023-TOOL-05-05 Call Topic Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery Website: http://thrombus.eu/ Deliverable # 06 No: D8.2 Deliverable Title: Dissemination and Communication Plan and Activities - Part A Deliverable Type: R Classification: PU Task: T8.1. Communication and dissemination plan and activities [M01-M42] Task Leader: SciGen [K. Pavlidi] Work Package: WP8. Dissemination and communication [M01-M42] Work Package Leader: SciGen [K. Pavlidi] Responsible Partner: SciGen Authors: K. Pavlidi [SciGen] Input from: - Peer Reviewers: General Assembly Due Date: M03 – 31 March 2024 Delivery Date: 31 March 2024 Revision Date: 12 November 2025 Document Status Version: 2.0 Status: Draft Consortium reviewed WP leader endorsed Coordinator endorsed D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 iv Revision History Version Date Modification Contributors 0.1 15 Mar 2024 New content K. Pavlidi [SciGen] 0.2 20 Mar 2024 Review and updates K. Pavlidi [SciGen] 0.3 29 Mar 2024 Review and incorporate changes from partners K. Pavlidi [SciGen] 1.0 31 Mar 2024 Editing for uniformity S. Didaskalou [ATHENA] E. Kaldoudi [ATHENA] 2.0 15 Nov 2025 Updates to address PR1 comments: − The table of messages to target groups updated to remove duplicated entries − Table 4 was updated to include more realistic KPIs and responsible partners − Calendars in the Annex were updated to include more details K. Pavlidi [SciGen] E. Kaldoudi [ATHENA] D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 v Contents About ThrombUS+ ...................................................................................................................................................... 1 Deliverable D8.2 Description ...................................................................................................................................... 1 Cite this Document as ................................................................................................................................................. 1 Terms and Definitions ................................................................................................................................................ 2 Executive Summary .................................................................................................................................................... 3 1. Communication and dissemination strategy ...................................................................................................... 4 1.1. Objectives .......................................................................................................................................................... 4 1.2. Target audiences ............................................................................................................................................... 4 1.3. Key messages .................................................................................................................................................... 6 1.4. Tools and channels ............................................................................................................................................ 7 1.4.1. Role of partners ........................................................................................................................................ 7 1.4.2. Social media channel selection ................................................................................................................. 8 1.4.3. Strategic plan and editorial calendar ........................................................................................................ 8 2. Communication Plan .......................................................................................................................................... 8 2.1. Internal communication .................................................................................................................................... 9 2.2. Communication activities .................................................................................................................................. 9 3. Dissemination Plan ............................................................................................................................................10 3.1. Dissemination activities ................................................................................................................................... 10 3.2. Scientific publications and publications of datasets ........................................................................................ 11 3.3. Stakeholder Advisory Board (SAB) ................................................................................................................... 12 3.4. Stakeholder events .......................................................................................................................................... 13 4. Dissemination Activities Monitoring and Reporting ..........................................................................................13 Annex: Social Media Strategic Plan ...........................................................................................................................14 Overview ....................................................................................................................................................................... 14 Platform-specific plans ................................................................................................................................................. 14 Hashtags ....................................................................................................................................................................... 15 Calendars ...................................................................................................................................................................... 16 D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 1 About ThrombUS+ Deep vein thrombosis (DVT) is the formation of a blood clot within the deep veins, most commonly those of the lower limbs, causing obstruction of blood flow. In 50% of people with DVT, the clot eventually breaks off and travels to the lung to cause pulmonary embolism. Clinical assessment of DVT is notoriously unreliable because up to 2/3 of DVT episodes are clinically silent and patients are symptom free even when pulmonary embolism has developed. Early diagnosis of DVT is crucial and despite the progress made in ultrasound imaging and plethysmography techniques, there is a need for new methods to enable continuous monitoring DVT diagnosis at the point of care. ThrombUS+ brings together an interdisciplinary team of industrial, technology, regulatory, social science and clinical trial experts to develop a novel wearable diagnostic device for point-of-care, operator free, continuous monitoring in patients with high DVT risk. The device will combine autonomous, AI driven DVT detection based on a novel wearable ultrasound hardware, impedance plethysmography and light reflection rheography for immediate detection of blood clot formation in the lower limb. Activity and other physiological measurements will be used to provide a continuous assessment of DVT risk and support DVT prevention via serious gaming. The aggregated data will drive an intelligence decision support unit that will provide accurate monitoring and alerts. Extended reality will be used to guide experts to design exercises and patients to use the device optimally. ThrombUS+ is intended for use by postoperative patients in the ward, during long surgical operations, cancer patients or otherwise bedridden patients at home or in care units, and women during pregnancy and postpartum. ThrombUS+ will use big data sets for AI training collected in the project via 3 large scale clinical studies and will validate the outcome in the clinical setting via 1 early feasibility study and 1 multi-center clinical trial. Deliverable D8.2 Description Dissemination and communication plan. Output of Task 8.1. According to the Grant Agreement (GA), D8.2 “Dissemination and Communication Plan and Activities - Part A” will define key messages and target audiences, selecting appropriate tools and channels to meet the information needs of the target audiences. The final version of the deliverable (Part B, delivered on M42) will also include any updates and an outline of related activities during the project. Cite this Document as Pavlidi K, Dissemination and communication plan and activities - Part A, Deliverable 8.2, ThrombUS+ Horizon Europe Innovation Action, EC Grant Agreement No. 101137227, 31 March 2024, Revised 15 November 2025. D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 2 Terms and Definitions Term Definition AI Artificial intelligence AI4EU A knowledge-sharing platform dedicated to AI-related projects. Argos/OpenAIRE An online machine-actionable tool to facilitate research data management DMP Data Management Plan DVT Deep Vein Thrombosis EOSC European Open Science Cloud EU European Union Facebook Online social networking service for the general public GA General Assembly (when within the context of project management procedure) Google Analytics A service generating statistics about a website’s traffic KPI Key Performance Indicator LinkedIn Online social networking service for professionals RDM Research Data Management SAB Stakeholder Advisory Board SEO Search Engine Optimization SlideShare Slide hosting service SME Small and Medium Enterprises Thrombosis The formation of a blood clot inside a blood vessel US Ultrasound WordPress Free and open-source blogging tool and content management system WP Work package X (Twitter) Online social networking service for the public and professionals YouTube Online social and streaming networking service D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 3 Executive Summary The goals of this document are: (a) to communicate the plan to increase the European and International visibility of the ThrombUS+ project through various communication initiatives, and (b) to communicate the plan to disseminate findings, innovations, and results to stakeholders, which include but are not limited to: − the medical device industry and − medical care providers. This document will identify key actors to optimize the project’s communication and dissemination material, which will be driven by web and social media, including ThrombUS+ mentions and wider market trends relevant to the project. It will also communicate the editorial strategy (press releases and articles in different EU languages, ThrombUS+ e-newsletter), presentations at public and academic events, training and contests, and participation in conferences. D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 4 1. Communication and dissemination strategy The communication and dissemination strategy is designed to ensure that the ThrombUS+ project's findings and outcomes reach a broad audience, fostering knowledge sharing and collaboration amongst the target audiences using key messages. Key elements of the communication strategy include target audience segmentation, key message development, content planning, and the involvement in and organization of scientific events. Key elements of the dissemination strategy include stakeholder identification and engagement, and thorough and efficient dissemination of research results to stakeholders. 1. Objectives The communication and dissemination strategy will employ a two-pronged approach: public awareness and stakeholder engagement. The communication strategy aims to increase public awareness of Deep Vein Thrombosis (DVT) and understanding of the importance of early detection. The project's identity, goals, and partners will be promoted simultaneously. Targeted communication will keep the public informed of project progress. The dissemination strategy aims to disseminate research results to stakeholders and encourage open dialogue. This interactive approach will allow for anticipating and addressing potential issues, gathering valuable feedback, and ultimately increasing project visibility. 2. Target audiences The communication and dissemination plan will cater to a diverse range of target audiences, mainly to the end users (i.e. patients), to medical experts and clinicians, and other stakeholders in the medical device field (Table 1). The scientific community will be a key focus, including peers in bioengineering, radiology/ultrasound, biotechnology, materials engineering, and mechanical engineering. Additionally, industries relevant to project development will be targeted, such as the medical device market, ultrasound transducer industry, microelectronics industry, and smart textiles and wearables industry. European professional organizations and associations will be included, such as the European Thrombosis and Haemostasis Alliance and the European Alliance for Medical and Biological Engineering and Science, alongside relevant industry associations (Figure 1). We also target medical doctors, residents, caretakers, researchers, and patients seeking informative content. To ensure broader impact, the plan will also encompass patients and carers, patient organizations, and consumer organizations. Finally, the general public, media outlets, health policymakers, and regulatory authorities will be engaged to raise public awareness and gain wider support for the project's goals. D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 11 Activity KPI Value Description Project Repository >100 files with deliverables, manuals, presentations, best lab practices. All 50 project deliverables will produce public documents, public deliverables will be public and sensitive deliverables will be accompanied by a publicly available executive summary. The repository will also include all dissemination and communication material files (flyers, posters, videos) and all publication files and scientific presentation files. Publications >12 publications on project results in scientific journals Scientific publications will be submitted in peer-reviewed Open Access journals or in subscription-based journals that offer an Open Access publishing option. Conferences >12 presentations and posters in scientific conferences Results will be presented both at scientific meetings and conferences. Example Conferences: Annual Conference of the European Society of Biomaterials; International Symposium on Ultrasonic Imaging and Tissue Characterization, IEEE International Ultrasonics Symposium (next 2025), Congress of World Federation for Ultrasound in Medicine and Biology. Datasets 1 big dataset published in EOSC with >3000 DVT ultrasound scans The outcome of Clinical Study A (T7.2). Exhibitions >2 participants HELEXPO (2 years), 2 exhibits during medical imaging conferences. HELEXPO is an International Commercial Exhibition held each year in September in Greece. ATHENA has a permanent presence in the exhibition and ThrombUS+ will be included in its booth. EchoNous also regularly participates in commercial exhibitions held. Stakeholder Events 4 events, >200 attendees 3 thematic events and 1 event at the European Congress of Radiology. Feedback Session >700 patients in the clinical studies B1, C1 and C2 20 doctors, 20 nurses and 10 clinical physiotherapists, from 5 EU countries. Project Meetings 4 per year At least 1 physical meeting per year, with bilateral technical meetings as needed. 6.2. Scientific publications and publications of datasets Scientific publications will be submitted in peer-reviewed Open Access journals or in subscription-based journals that offer an Open Access publishing option, respecting the “Guidelines on Open Access to Scientific Publications and Research Data in Horizon 2020.” An indicative list of open access journals in which the project plans to publish research findings: − npj Digital Medicine − Journal of Thrombosis and Haemostasis − Circulation − IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control − IEEE Transactions on Medical Imaging − IEEE Biomedical and Health Informatics − Annals of Biomedical Engineering D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 12 Manuscripts will be circulated to all partners in advance of submission and partners will be invited to comment. Notwithstanding this, absolute confidentiality will be enforced so as to not jeopardize individual partners’ or the Consortium’s claim to intellectual property rights. Within the ThrombUS+ project, multiple datasets will be generated, including Clinical Study data. To achieve higher dissemination levels, the following 4 steps are planned: 1. Implement the DMP (Data Management Plan) among consortium partners to ensure that datasets are compliant with FAIR (Findable, Accessible, Interoperable, Reusable) principles. 2. Register ThrombUS+ to the EOSC (European Open Science Cloud) environment. EOSC is an environment where data, tools and services can be published, found, and reused. 3. Explore and operate the AI4EU platform. AI4EU is a knowledge-sharing platform dedicated to AI-related projects. 4. Describe datasets in Argos/OpenAIRE tool and make them available through the EOSC platform. According to the DOA, the Clinical Study A data set containing ultrasound images from DVT examination will be fully public, further increasing the project’s impact, especially within the scientific community (Figure 3). Figure 3. Steps for publishing Clinical Study A dataset. 6.3. Stakeholder Advisory Board (SAB) As part of T8.4, the SAB will be composed of representatives of opinion leaders, regulators, industry, health professionals’ organizations, patients’ organizations, and international associations devoted to the use of mobile technologies to improve health (Table 6). Names and short CVs of persons comprising the SAB are included in D1.1. Table 6. Explaining the role of the Stakeholder Advisory Board Group Description Representatives from various stakeholder groups Purpose Provide input, feedback, and guidance Ensure project portfolio alignment with strategic vision and project mission Reflect stakeholder needs, expectations, and interests Functions Resolve conflicts among stakeholders Mitigate project risks Enhance communication between industry partners Leverage interdisciplinary collaboration Key Responsibilities Advise the project portfolio manager Advise the project portfolio steering committee Representatives and experts invited to join the SAB will be identified by project partners. Outreach and invitations to join the SAB will be extended by the proximate partner within the Consortium on its behalf, or SciGen if no prior relationship to any project partner exists. D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 13 The main goal of T8.4 is to ensure ThrombUS+ potential adopters and EU citizens inform the co-production of the wearable DVT monitoring and prevention system developed in the project. Using a combination of best practice citizen engagement approaches, we will work with (instead of for) EU citizens and professionals. 6.4. Stakeholder events Annual SAB meetings will serve as a discussion platform to consult on different aspects of the project and its progress, and provide feedback and guidance to project partners. 7. Dissemination Activities Monitoring and Reporting Dissemination activities will be regularly reported internally and officially summarized annually. A second report on the communication and dissemination activities of the project, titled “Communication and Dissemination Plan and Activities - Part B,” will be submitted under D8.4 in M42, along with a report on stakeholder awareness and engagement. D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 14 Annex: Social Media Strategic Plan Overview An overview of planned tasks and targeted metrics for disseminating and communicating the ThrombUS+ project and results in social media and website are shown in Table 7. Table 7 – Overview of social media plan. 1 KPIs by M42: >1500 followers across all accounts >500 video views >5000 website visits 2 Ongoing Tasks: − Monitoring of all SM channels for DVT news and research updates − Interaction (Like, Follow, Retweet/QT, Comment) with other accounts related to: 1| Medical technology 2| Biotechnology 3| Horizon EU 4| Medical research 5| Medical news 3 Other information March is DVT awareness month Platform-specific plans Table 8 – Content posting plans across various platforms. Platform Plans LinkedIn − Post at least twice per month. − The number of the month post will be a monthly LinkedIn post that shares a relevant number or statistic related to deep vein thrombosis. This is a way to distribute the workload of content creation evenly amongst the project partners while ensuring a steady flow of content for the entire duration of the project (Figure 4). X (formerly Twitter) − Post circumstantial updates – when there is a meeting, newsletter, breakthrough, etc. − Observe and consistently interact with relevant accounts (such as project partners) and hashtags such as #DVT and #HorizonEU. Facebook − Post 1-2 times per month. − Prioritize informational posts, infographics, long-form content that will resonate with a general audience. Website & e-Newsletter − Consistency of posts is key to building an engaged audience. − A Meet the Partner post will be a one-time post for each partner on the ThrombUS+ website (thrombus.eu), wherein they introduce their organization, its history, and its role and involvement in the ThrombUS+ project (Figure 4). D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 15 Figure 4. Meet the Partner: ATHENA RC is already posted on the thrombus.eu website. Hashtags − Use 3-5 per post. − Combine short-tail and long-tail keywords and hashtags. − Use trending hashtags when appropriate and relevant. − Indicative hashtags: 1| #DVT 2| #thrombosis 3| #DeepVeinThrombosis 4| #HorizonEU 5| #HorizonEurope 6| #EarlyDetection 7| #EarlyDiagnosis 8| #MedTech 9| #MedTwitter D8.2 | Dissemination & Communication Plan v2.0 | 12 Nov 2025 16 Calendars Table 9. Calendar for the “Number of the Month” post on LinkedIn. The number of the month post will be a monthly LinkedIn post that shares a relevant number or statistic related to deep vein thrombosis or the project. The calendar below shows the partner responsible to provide the number/statistic per month. Month Partner Month Partner Month Partner Month Partner Mar 2024 ATHENA Jan 2025 GNP Nov 2025 VERMON Sep2026 HSV Apr 2024 KTU Feb2025 CSS-IRCCS Dec 2025 Fraunhofer Oct 2026 VDE May 2024 VERMON Ma 2025 HSV Jan 2026 TELEMED Nov 2026 MEDEA Jun 2024 Fraunhofer Ap 2025 VDE Feb 2026 EchoNous Dec 2026 PHAZE Jul 2024 TELEMED May 2025 MEDEA Mar 2026 MEDIS Jan 2027 PBY Aug 2024 EchoNous Ju 2025 PHAZE Apr 2026 ComfTech Feb 2027 SciGen Sep 2024 MEDIS Jul 2025 PBY May 2026 TAU May2027 ATHENA Oct 2024 ComfTech Aug 2025 SciGen Jun 2026 LSMU Apr 2027 KTU Nov 2024 TAU Sept 2025 ATHENA Jul 2026 GNP May 2027 VERMON Dec 2024 LSMU Oct 2025 KTU Aug 2026 CSS-IRCCS Jun 2027 Fraunhofer Table 10. Calendar for the “Meet the partner” post on the website www.thrombus.eu The Meet the Partner post will be a one-time post for each partner on the ThrombUS+ website, wherein they introduce their organization, its history, and its role and involvement in the ThrombUS+ project. The calendar below shows the partner responsible to provide the number/statistic per month. Month Partner Month Partner Mar 2024 ATHENA Sept 2025 LSMU May 2024 KTU Nov 2025 GNP Jul 2024 VERMON Jan 2026 CSS-IRCCS Sep 2024 Fraunhofer Mar 2026 HSV Nov 2024 TELEMED May 2026 VDE Jan 2025 EchoNous Jul 2026 MEDEA Mar 2025 MEDIS Sep 2026 PHAZE May 2025 ComfTech Nov 2026 PBY Jul 2025 TAU Jan 2027 SciGen